AIM
ABMD

Acrospire Investment Management’s Abiomed Inc ABMD Stock Holding History

Acrospire Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-406
Closed -$58K – 1616
2017
Q2 		$58K Buy
406
+200
+97% +$26.9K 0.05% 716
2017
Q1 		$26K Buy
+206
New +$23.9K 0.02% 1474
2016
Q4 		– Sell
-200
Closed -$26K – 2476
2016
Q3 		$26K Hold
200
– – 0.02% 1411
2016
Q2 		$22K Sell
200
-500
-71% -$49.7K 0.02% 1497
2016
Q1 		$66K Buy
+700
New +$59.1K 0.05% 682

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

Acrospire Investment Management's ABMD Position: Q3 2017 in Review

Acrospire Investment Management sold out of Abiomed Inc (ABMD) in Q3 2017, closing a stake of 406 shares — an estimated $58K sold.

Acrospire Investment Management first reported a position in ABMD in Q1 2016 and held it in 5 quarters. The position peaked at $66K in Q1 2016. 318 funds tracked by Wall St. Rank hold ABMD as of Q3 2017.

  • Acrospire Investment Management reported no remaining Abiomed Inc position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 406 Abiomed Inc shares in Q3 2017, an estimated $58K.
  • Acrospire Investment Management first reported a position in Abiomed Inc in Q1 2016 and held it in 5 quarters.
  • Acrospire Investment Management's Abiomed Inc position peaked at $66K in Q1 2016.
  • 318 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.